COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 360 participants.
Also called NCT01552187
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 360 participants
- Sponsor
- Maria Vittoria Hospital
- Registry
-
NCT01552187 -
2011-005835-21
-
- Other papers using this trial's data
- Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01552187. Randomized; quadruple masking; primary purpose prevention. Start 2012-03 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)
- Acronym
- COPPS-2
- Condition
- Cardiac Surgery
- Condition
- Post-pericardiotomy Syndrome
- Condition
- Atrial Fibrillation
- Condition
- Pericardial Effusion
- Condition
- Pleural Effusion
- Intervention (Drug)
- Colchicine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Maria Vittoria Hospital
Record details
- Record id
cardio:ct-nct01552187- Content hash
b5ac96cebf598c1cd09096ee402a77d6a114ba3dc35066028fb800cf9821debf